Christopher R. Fenimore, SVP Controller at REGENERON PHARMACEUTICALS, INC. (REGN), sold 4,384 shares at $806.47 ($3.5M) on 2023-03-23, disclosed to the SEC on 2023-03-27.
Scheduled sale ($3.5M) by SVP Controller under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $806.47 | 2,192 | $1.8M | 50.0% |
| 2 | $806.47 | 2,192 | $1.8M | 50.0% |
| Total | $806.47 avg | 4,384 | $3.5M | 100% |
| Filing → |
| REGN | SELL | 2023-12-29 | $4.2M | — | Filing → |
| REGN | SELL | 2023-12-26 | $3.3M | — | Filing → |
| REGN | SELL | 2022-10-07 | $1.4M | — | Filing → |